Slingshot members are tracking this corporate initiative:
CymaBay In Ongoing Discussions With Potential Partners For The Phase 3 Development of Arhalofenate
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Mar 29, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Don’t see a project related to the strategic initiative you care about?
Related Keywords Potential Partnership, Phase 3 Development, Arhalofenate, Gout, Serum Uric Acid